These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14756103)

  • 1. [Alfadil--positive documentation when it comes to safety is missing].
    Furberg C
    Lakartidningen; 2003 Dec; 100(51-52):4329; discussion 4330. PubMed ID: 14756103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].
    Gustafsson LL
    Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Doxazosin and heart failure: a clinical conclusion is wanted].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 Dec; 100(51-52):4328. PubMed ID: 14756102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alfadil and heart failure--clinical conclusions do exist!].
    Lohm L; Lindh E; Frösing R
    Lakartidningen; 2003 Dec; 100(49):4112-3. PubMed ID: 14717078
    [No Abstract]   [Full Text] [Related]  

  • 5. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Janssen CA
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):135; author reply 135-6. PubMed ID: 12577776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Doxazosin and heart failure: truthful information--for the sake of patients].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 Nov; 100(48):4011-2. PubMed ID: 14717098
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxazosin, an inferior antihypertensive agent?
    Furberg CD
    J Hum Hypertens; 2002 Jun; 16(6):375-7. PubMed ID: 12037690
    [No Abstract]   [Full Text] [Related]  

  • 8. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K; van der Tuin J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J; Solar M
    Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin for the management of hypertension: implications of the findings of the ALLHAT trial.
    Poulter N; Williams B
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1170-2. PubMed ID: 11724218
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxazosin arm of the ALLHAT study discontinued: how equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Messerli FH; Grossman E
    Curr Hypertens Rep; 2000 Jun; 2(3):241-2. PubMed ID: 10981155
    [No Abstract]   [Full Text] [Related]  

  • 12. On call. I'm a 76-year-old man with an enlarged prostate. I've been taking Cardura and it's helped a lot, but my doctor stopped it because he said a study found the drug could cause heart failure. Now I'm getting up three or four times a night again. Is Cadura safe?
    Simon HB
    Harv Mens Health Watch; 2001 Jul; 5(12):8. PubMed ID: 11511462
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial.
    Vidt DG
    Cleve Clin J Med; 2000 Jun; 67(6):429-33. PubMed ID: 10860225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin gastrointestinal therapeutic system: a clinical perspective.
    Mann SJ
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):207-8. PubMed ID: 16522999
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxazosin in the current treatment of hypertension.
    Wykretowicz A; Guzik P; Wysocki H
    Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line antihypertensive therapy. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.
    Feldman RD; Campbell N; Larochelle P
    Lancet; 2000 Aug; 356(9228):509. PubMed ID: 10981916
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart lines. Cardura update.
    Harv Heart Lett; 2001 Sep; 12(1):5-6. PubMed ID: 11572810
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alpha-blockers in therapy of arterial hypertension. No longer the drug of first choice].
    Faulhaber HD
    MMW Fortschr Med; 2001 May; 143(22):30-2. PubMed ID: 11460395
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxazosin and congestive heart failure.
    Messerli FH
    J Am Coll Cardiol; 2001 Nov; 38(5):1295-6. PubMed ID: 11691497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doxazosin. A postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension].
    Dominiak P
    Internist (Berl); 1993 Jul; 34(7):682-7. PubMed ID: 8103510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.